Shundong Cang
1 ta ish
Zhengzhou University
Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives
Chenyang Jiang, Hao Sun, Zhongxing Jiang +3
Sharh maqola20242 iqtibosABI
Kashfiyot
Xizmatlar
Ishlab chiquvchilar uchun
1 ta ish
Zhengzhou University
Chenyang Jiang, Hao Sun, Zhongxing Jiang +3